NIFTY
-24.45  -0.21%
 11699.65
S&P BSE SENSEX
-71.53  -0.18%
 39122.96
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 24-Jun-2019
NSE
-16.15    -2.68%
Rs. 586.30
 
Days Low
Rs. 582.8
Days High
Rs. 611

Open Rs. 611
 
52 week Low
Rs. 566
52 week High
Rs.838
 
 
Bid :                 0.00 (0)
Offer :        584.95 (84)
BSE
Rs.586.20
-16.15    -2.68%
on 24-Jun-2019
BSE
-16.15    -2.68%
Rs. 586.20
 
Days Low
Rs. 582.3
Days High
Rs. 614.7

Open Rs. 614.7
 
52 week Low
Rs. 565.05
52 week High
Rs.838
 
 
Bid :                 0.00 (0)
Offer :        584.95 (84)
NSE
Rs.586.30
-16.15    -2.68%
 
 
Last Price (Rs.)  586.20 Value  91201276.00
Net Change (Rs.)  -16.15 Best Buy  0.00
Volume  154911 Best Sell  584.95
Prev.Close (Rs.)  602.35 Best Quantity  0
Open (Rs.)  611.00 Sell Quantity  84
High (Rs.)  611.00 52-Week High (Rs.)  838.00
Low (Rs.)  582.80 52-Week Low (Rs.)  566.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  343463.73
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Share Capital585.90 585.90 585.20 
Currents Investments0.20 0.20 0.20 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 383.60 920385 95.21 0.00 0.72
Cipla 549.75 443004 195.85 30.14 0.55
Divis Lab 1576.25 418445 262.68 48.12 1.02
Dr. Reddys Lab 2511.80 417227 763.61 73.55 0.80
Piramal Enterprises 1945.60 386876 1176.18 67.64 1.44
 
Mutual Funds Holdings
Scheme Name% HoldNo.Shares
HDFC Balanced Advantage Fund(G) 1.64 8570828
HDFC Hybrid Equity Fund(G) 2.54 7361000
HDFC Equity Fund(G) 1.90 5457526
SBI BlueChip Fund-Reg(G) 1.34 3779171
HDFC Top 100 Fund(G) 1.72 3632450
 
Quarterly Result
(Rs .in millions)Mar 2019Dec 2018Sep 2018
Net Sales32805.8032481.0031703.90
Operating Profit7626.507351.906111.50
PBDT7278.106937.805803.50
Net Profit4601.404635.103809.50
More> 
 
Company News
6/21/2019 12:00:00 AM
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations...
6/21/2019 12:00:00 AM
Aurobindo Pharma receives warning letter from USFDA for API manufactur...
6/21/2019 12:00:00 AM
Aurobindo Pharma informs about disclosure
More>
 
Ratios
   Earnings Per Share (Rs)30.94 
   Book NAV/Share(Rs)170.38 
   PAT Margin (%)17.59 
   Asset Turnover(x)0.71 
   PER(x)18.01 
   Yield(%)0.45 
   EV/Core EBITDA(x)13.13 
   M Cap / Sales3.18 
   Net Sales Growth(%)6.90 
   PAT Growth(%)6.21 
   Total Debt/Equity(x)0.37 
   Current Ratio(x)1.56 
   Quick Ratio(x)0.97 
   Total Debt/Mcap(x)0.11 
More>